Scott Andrew Smith insider trades
Open-market stock purchases and sales by Scott Andrew Smith, Chief Executive Officer at Viatris Inc, from SEC Form 4 filings since Oct 27, 2014.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +69%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 6, 2026 | VTRS Viatris Inc | Sold (not open market) | $694K |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Sold (not open market) | $34.5K |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 4, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 4, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 4, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 4, 2026 | VTRS Viatris Inc | Sold (not open market) | $535K |
| Mar 4, 2026 | VTRS Viatris Inc | Sold (not open market) | $50.4K |
| Mar 3, 2026 | VTRS Viatris Inc | Sold (not open market) | $7.5M |
| Mar 3, 2026 | VTRS Viatris Inc | Sold (not open market) | $796K |
| Mar 3, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 3, 2026 | VTRS Viatris Inc | Sold (not open market) | $106K |
| Mar 3, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 3, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 3, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 3, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
Companies traded
- VTRS Viatris Inc: 2 buys, last Mar 6, 2026
- BCAB BioAtla, Inc: 18 sales, last Jun 18, 2025
- APGN Apexigen, Inc: other filings, last Aug 23, 2023
- SBPH Spring Bank Pharmaceuticals, Inc: 1 buy, last Jun 24, 2020
- CELG Celgene Corp /de/: other filings, last Feb 17, 2018
- TTNP Titan Pharmaceuticals Inc: other filings, last Sep 15, 2017